top of page
Medical Checkup

ATLAS

Trial Enrolment Status

OPEN

Disease Under Study

ASTHMA

Duration

~3 Years

About the Trial

Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma

Mechanism of Action:

Anti IL-4

Duration of Study

~3 Years

Phase

​

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Nusrat Jahan

Dr. Philteos and Associates | Dynamic Drug Advancement Limited

Address:

Hours:

601 Harwood Avenue South, Suite 201

Ajax, Ontario L1S 2J5

M-F:

9:00am - 5:00pm

Closed on statutory holidays

Main Office Phone: 

 

 

Main Office Fax:   

Clinical Trial Phone:

Clinical Trial Fax: 

Dr. Philteos: (905) 427-1419

Dr. Chelvanathan: (905) 239 0225

Dr. O'Loghlen: (905) 239 0221

(905) 427-0346

(365) 885-9086

(905) 239-2399

©2022 by Dynamic Drug Advancement. Proudly created with Wix.com

bottom of page